Differential regulation of CD44 expression by lipopolysaccharide (LPS) and TNF-α in human monocytic cells: Distinct involvement of c-Jun N-terminal kinase in LPS-induced CD44 expression

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 5660-5672

  Gee, Katrina ^a   Lim, Wilfred ^a   Ma, Wei ^a   Nandan, Devki ^a   Diaz Mitoma, Francisco ^a   Kozlowski, Maya ^a   Kumar, Ashok ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HERMES ANTIGEN; RECOMBINANT INTERLEUKIN 10; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STRESS ACTIVATED PROTEIN KINASE;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0037111304     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.5660     Document Type: Article

References (70)

1. Heinzelmann, M., H. C. J. Polk, A. Chernobelsky, T. P. Stites, and L. E. Gordon. 2000. Endotoxin and muramyl dipeptide modulate surface receptor expression on human mononuclear cells. Immunopharmacology 48:117.
2. Verhasselt, V., C. Buelens, F. Willems, D. De Groote, N. Haeffner-Cavaillon, and M. Goldman. 1997. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway. Immunol. 158:2919.
3. Levesque, M. C., and B. F. Haynes. 1997. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-α and is inhibited by IL-4 and IL-13. J. Immunol. 159:6184.
4. Pure, E., and C. A. Cuff. 2001. A crucial role for CD44 in inflammation. Trends Mol. Med. 7:213.
5. Siegelman, M. H., H. C. DeGrendele, and P. Estess. 1999. Activation and interaction of CD44 and hyaluronan in immunological systems. J. Leukocyte Biol. 66:315.
6. Lesley, J., R. Hyman, and P. W. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271.
7. Naor, D., R. V. Sionov, and D. Ish-Shalom. 1997. CD44: Structure, function, and association with the malignant process. Adv. Cancer Res. 71:241.
8. Shimizu, Y., G. A. Van Seventer, R. Siraganian, L. Wahl, and S. Shaw. 1989. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143:2457.
9. Miyake, K., K. L. Medina, S. Hayashi, S. Ono, T. Hamaoka, and P. W. Kincade. 1990. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 171:477.
10. Stamenkovic, I., A. Aruffo, M. Amiot, and B. Seed. 1991. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 10:343.
11. Gunthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13.
12. Dougherty, G. J., D. L. Cooper, J. F. Memory, and R. K. Chiu. 1994. Ligand binding specificity of alternatively spliced CD44 isoforms: Recognition and binding of hyaluronan by CD44R1. J. Biol. Chem. 269:9074.
13. Katoh, S., Z. Zheng, K. Oritani, T. Shimozato, and P. W. Kincade. 1995. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 182:419.
14. Levesque. M. C., and B. F. Haynes. 1999. TNF-α and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44. Cell. Immunol. 193:209.
15. Kryworuchko, M., F. Diaz-Mitoma, and A. Kumar. 1999. Interferon-γ inhibits CD44-hyaluronan interactions in normal human B lymphocytes. Exp. Cell Res. 250:241.
16. Kryworuchko, M., K. Gee, F. Diaz-Mitoma, and A. Kumar. 1999. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4. Cell. Immunol. 194:54.
17. Mackay, C. R., H. J. Terpe, R. Stauder, W. L. Marston, H. Stark, and U. Gunthert. 1994. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol. 124:71.
18. Murakami, S., K. Miyake, C. H. June, P. W. Kincade, and R. J. Hodes. 1990. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol. 145:3618.
19. Legras, S., J. P. Levesque, R. Charrad, K. Morimoto, C. Le Bousse, D. Clay, C. Jasmin, and F. Smadja-Joffe. 1997. CD44-mediated adhesiveness of human hematopoietic progenitors to hyaluronan is modulated by cytokines. Blood 89:1905.
20. Sionov, R. V., and D. Naor. 1998. Calcium- and calmodulin-dependent PMA-activation of the CD44 adhesion molecule. Cell Adhes. Commun. 6:503.
21. Fichter, M., R. Hinrichs, G. Eissner, B. Scheffer, S. Classen, and M. Ueffing. 1997. Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C. Oncogene 14:2817.
22. Maltzman, J. S., J. A. Carman, and J. G. Monroe. 1996. Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes. Mol. Cell. Biol. 16:2283.
23. Fitzgerald, K. A., and L. A. O'Neill. 1999. Characterization of CD44 induction by IL-1: A critical role for Egr-1. J. Immunol. 162:4920.
24. DeFranco, A. L., M. T. Crowley, A. Finn, J. Hambleton, and S. L. Weinstein. 1998. The role of tyrosine kinases and MAP kinases in LPS-induced signaling. Prog. Clin. Biol. Res. 397:119.
25. Lewis, T. S., P. S. Shapiro, and N. G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49.
26. Liu, M. K., P. Herrera-Velit, R. W. Brownsey, and N. E. Reiner. 1994. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J. Immunol. 153:2642.
27. Hambleton, J., S. L. Weinstein, L. Lem, and A. L. DeFranco. 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. USA 93:2774.
28. Hatzoglou, A., J. Roussel, M. F. Bourgeade, E. Rogier, C. Madry, J. Inoue, O. Devergne, and A. Tsapis. 2000. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-κB, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J. Immunol. 165:1322.
29. Darnay, B. G., and B. B. Aggarwal. 1997. Early events in TNF signaling: A story of associations and dissociations. J. Leukocyte Biol. 61:559.
30. Ma, W., W. Lim, K. Gee, S. Aucoin, D. Nandan, M. Kozlowski, F. Diaz-Mitoma, and A. Kumar. 2001. The p38 mitogen activated kinase pathway regulates the human IL-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 17:13664.
31. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686.
32. Lee, J. C., and P. R. Young. 1996. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukocyte Biol. 59:152.
33. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98:13681.
34. Daftarian, P. M., A. Kumar, M. Kryworuchko, and F. Diaz-Mitoma. 1996. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-α. J. Immunol. 157:12.
35. Gee, K., M. Kozlowski, M. Kryworuchko, F. Diaz-Mitoma, and A. Kumar. 2001. Differential effect of IL-4 and IL-13 on CD44 expression in the Burkitt's lymphoma B cell line b130/b95-8 and in Epstein-Barr virus (EBV) transformed human B cells: Loss of IL-13 receptors on Burkitt's lymphoma B cells. Cell. Immunol 211:131.
36. Lim, W., W. Ma, K. Gee, S. Aucoin, D. Nandan, F. Diaz-Mitoma, M. Kozlowski, and A. Kumar. 2002. Distinct role of p38 and c-jun N-terminal kinases in IL-10-dependent and IL-10-independent regulation of the co-stimulatory molecule B7.2 in lipopolysaccharide-stimulated human monocytic cells. J. Immunol. 168:1759.
37. Arrighi, J. F., M. Rebsamen, F. Rousset, V. Kindler, and C. Hauser. 2001. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers. J. Immunol. 166:3837.
38. De Cesaris, P., D. Starace, G. Starace, A. Filippini, M. Stefanini, and E. Ziparo. 1999. Activation of Jun N-terminal kinase/stress-activated protein kinase pathway by tumor necrosis factor a leads to intercellular adhesion molecule-1 expression. J. Biol. Chem. 274:28978.
39. Foey, A. D., S. L. Parry, L. M. Williams, M. Feldmann, B. M. Foxwell, and F. M. Brennan. 1998. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: Role of the p38 and p42/44 mitogen-activated protein kinases. J. Immunol. 160:920.
40. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar. D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, and S. W. Landvatter. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
41. Hirasawa, N., Y. Sato, Y. Fujita, S. Mue, and K. Ohuchi. 1998. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells. J. Immunol. 161:4939.
42. Whitmarsh, A. J., P. Shore, A. D. Sharrocks, and R. J. Davis. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403.
43. Zanke, B. W., K. Boudreau, E. Rubie, E. Winnett, L. A. Tibbles, L. Zon, J. Kyriakis, F. F. Liu, and J. R. Woodgett. 1996. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr. Biol. 6:606.
44. Verheij, M., R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, J. M. Kyriakis, et al. 1996. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75.
45. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392.
46. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443.
47. Muzio, M., G. Natoli, S. Saccani, M. Levrero, and A. Mantovani. 1998. The human toll signaling pathway: Divergence of nuclear factor KB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187:2097.
48. Ninomiya-Tsuji, J., K. Kishimoto, A. Hiyama, J. Inoue, Z. Cao, and K. Matsumoto. 1999. The kinase TAKI can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398:252.
49. Yang, R. B., M. R. Mark, A. L. Gurney, and P. J. Godowski. 1999. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J. Immunol. 163:639.
50. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959.
51. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424.
52. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95.
53. O'Farrell, A. M., Y. Liu, K. W. Moore, and A. L. Mui. 1998. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and -independent pathways. EMBO J. 17:1006.
54. Takeda, K., B. E. Clausen, T. Kaisho, T, Tsujimura, N. Terada, I. Forster, and S. Akira. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39.
55. INK4D by IL-10 contributes to inhibition of macrophage proliferation. J. Immunol. 164:4607.
56. Toumier, C., A. J. Whitmarsh, J. Cavanagh, T. Barrett, and R. J. Davis. 1997. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase, Proc. Natl. Acad. Sci. USA 94:7337.
57. Derijard, B., J. Raingeaud, T. Barrett, I. H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682.
58. 2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. USA 94:3004.
59. Guan, Z., S. Y. Buckman, A. P. Pentland, D, J, Templeton, and A. R. Morrison. 1998. Induction of cyclooxygenase-2 by the activated MEKK1→SEK1/MKK4→p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 273:12901.
60. Jonat, C., H. J. Rahmsdorf, K. K. Park, A. C. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189.
61. Schule, R., P. Rangarajan, S. Kliewer, L. J. Ransone, J. Bolado, N. Yang, I. M. Verma, and R. M. Evans. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217.
62. Shalom-Barak, T., J. Quach. and M. Lotz. 1998. Interieukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB. J. Biol. Chem. 273:27467.
63. Gupta, S., T. Barrett, A. J. Whitmarsh, J. Cavanagh, H. K. Sluss, B. Derijard, and R. J. Davis. 1996. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:2760.
64. Yang, D. D., C. Y. Kuan, A. J. Whitmarsh, M. Rincon, T. S. Zheng, R. J. Davis, P. Rakic, and R. A. Flavell. 1997. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389:865.
65. + T cells to Th1 cells requires MAP kinase JNK2. Immunity 9:575.
66. Dong, C., D. D. Yang, C. Tournier, A. J. Whitmarsh, J. Xu, R. J. Davis, and R. A. Flavell. 2000. JNK is required for effector T-cell function but not for T-cell activation. Nature 405:91.
67. Constant, S. L., C. Dong, D. D. Yang, M. Wysk, R. J. Davis, and R. A. Flavell. 2000. JNK1 is required for T cell-mediated immunity against Leishmania major infection. J. Immunol. 165:2671.
68. Cao, X. M., R. A. Koski, A. Gashler, M. McKieman, C. F. Morris, R. Gaffney, R. V. Hay, and V. P. Sukhatrne. 1990. Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol. Cell. Biol. 10:1931.
69. Seyfert, V., L. S. McMahon, W. Glenn, X. M. Cao, V. P. Sukhatme, and J. G. Monroe. 1990. Egr-1 expression in surface Ig-mediated B cell activation: Kinetics and association with protein kinase C activation. J. Immunol. 145:3647.
70. Lim, C. P., N. Jain, and X. Cao. 1998. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene 16:2915.